Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT04488432 Completed - Metabolic Syndrome Clinical Trials

Endocrine, Bone And Metabolic Disorders In Adults After Allogeneic Stem-cell Transplant

ENDOCALLOGREFF
Start date: November 27, 2019
Phase:
Study type: Observational

Allogeneic hematopoietic stem cell transplantations (allo-HSCT) is often indicated in malignant hematologic diseases. Conditioning regimens, used to reduce the tumor burden and to prevent transplant rejection, are based on chemotherapy alone or combined with total body irradiation (TBI). Endocrine complications are frequent transplant-related side effects. Investigators have been well described in children studies but less in adulthood. The objective of this study is to assess retrospectively endocrine, bone and metabolic disorders in adult patients, 12 months after allo-HSCT.

NCT ID: NCT04467138 Completed - Clinical trials for Lipid Metabolism Disorders

High Dose Intravenous Fish Oil Reduces Inflammation

Start date: January 31, 2020
Phase:
Study type: Observational

Retrospective analysis of 51 patients (27 female, 24 male, mean age 51.5±12.6 years) who received all-in-one PN including amino acids, glucose and lipids supplemented with pure fish oil LE was performed.

NCT ID: NCT04458662 Completed - Inflammation Clinical Trials

Iron and Muscular Damage: FEmale Metabolism and Menstrual Cycle During Exercise

IronFEMME
Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

This project is an observational controlled randomized counterbalance study. One hundred and three physically active and healthy women were selected to participate in the IronFEMME Study, of which 57 were eumenorrheic, 30 were oral contraceptive users (OCP) and 16 were postmenopausal women. The project consisted on two sections carrying out at the same time: Iron metabolism (Study I) and Muscle damage (Study II). For the study I, the exercise protocol consisted on an interval running test (8 bouts of 3 min at 85% of the maximal aerobic speed), whereas the study II protocol was based on an eccentric-based resistance exercise protocol (10 sets of 10 repetitions of plate-loaded barbell parallel back squats at 60% of their 1RM with 2 min of rest between sets). In both studies, eumenorrheic participants were evaluated at three specific moments of the menstrual cycle: Early-follicular phase, late-follicular phase and mid-luteal phase; OCP performed the trial at two moments: Withdrawal phase and active pill phase. Lastly, postmenopausal women were tested only once, since their hormonal status does not fluctuate. The three-step method was used to verify the menstrual cycle phase: calendar counting, blood analyses confirmation and urine-based ovulation kits. Blood samples were obtained to measure sexual hormones (e.g., 17β-Estradiol, Progesterone), iron metabolism parameters (e.g., Hepcidin, Iron, Ferritin, Transferrin) and muscle damage related markers (e.g., Creatine Kinase, Myoglobin, Lactate Dehydrogenase).

NCT ID: NCT04450810 Completed - Clinical trials for Periodontal Diseases

Role of NLRP3 in Periodontitis and Diabetes

Start date: June 1, 2014
Phase:
Study type: Observational

NLRP3 plays a key role in endothelial function and may be a link for the known interaction of periodontitis and diabetes. The investigators compared the impact of gingival health, periodontitis (CP), diabetes or of both diseases (CP +diabetes) on saliva and serum NLRP3levels.

NCT ID: NCT04396288 Completed - Clinical trials for Bone Diseases, Metabolic

Ultrasound Imaging-based Measurement of Intra-osseous Vascular Response

Start date: September 14, 2021
Phase: N/A
Study type: Interventional

Blood circulation within bone is thought to have a key role in bone growth, in fracture healing and in the development of bone diseases like osteoporosis. Current medical imaging techniques such as conventional ultrasonography fail to detect blood circulation within bone. The investigators propose to develop a new type of ultrasonography called intraosseous functional ultrasonography that will enable the detection and the characterization of blood circulation in solid bone tissue, marrow and soft tissues surrounding bone (muscle for instance). Because most soft tissues are essentially made of water, the speed of sound in soft tissues is close to that in water and it varies only a little between different types of soft tissues. For this reason, clinical ultrasound scanners used for ultrasonography assume that the speed of sound in the human body is the same for all types of soft tissues. This assumption is reasonable in soft tissues, but it does not hold in bone because solid bone tissue is much stiffer than soft tissues. Seismologists have extensive experience in producing images of the structure of the Earth based on the analysis of elastic waves which follow the same laws of Physics as ultrasound waves. The subsurface of the Earth contains layers of solid materials and liquids, consequently it is very similar to a region of the human body containing bone and soft tissues. Therefore the investigators will first work on the adaption of time-tested seismic imaging methods to make ultrasonography of bone possible. Once a correct image of bone is obtained, the investigators will use an ultrasound scanner dedicated to research to repeat this image hundreds of times per second, very much like a slow motion video. Because blood is moving while bone is still, the intensity in the image is being slightly changed where blood is moving. Thus the analysis of these changes makes it possible to detect and characterize blood flow within bone. In this way the investigators expect to be able to detect blood flowing with a speed as low as a few millimeters per second. Finally the sensitivity of the technique to detect and characterize blood circulation in bone will be evaluated in patients at the hospital and in healthy volunteers. The success of this work will help gaining knowledge on the role of blood circulation within bone. In the long term, it may help in the diagnosis of bone diseases.

NCT ID: NCT04369833 Completed - Diabetes Mellitus Clinical Trials

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform

Start date: May 11, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to develop a personalized diabetes prevention and management platform based on artificial intelligence model using mathematical analysis.

NCT ID: NCT04346836 Completed - Obesity Clinical Trials

Low-intensity Exercise in Metabolic Syndrome

Start date: May 6, 2018
Phase: N/A
Study type: Interventional

People with metabolic syndrome (MetS) are characterized by a lower quality of life in terms of reduced vital activity, emotional state, and social functioning. Therefore, the investigator's aim was to determine the impact of low-intensity exercise and psychoeducation on depression symptoms and self-perceived stress in women with MetS.

NCT ID: NCT04318509 Completed - Metabolic Disease Clinical Trials

Market Research - Acceptability Study for a New PKU Protein Substitute

Start date: February 4, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate that a new protein substitute is acceptable and well tolerated in children with PKU.

NCT ID: NCT04311307 Completed - Clinical trials for Glycogen Storage Disease Type IA

Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia

ENGLUPRO GSDIa
Start date: January 19, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Glycogen storage disease type Ia (GSDIa) subjects retain a limited capacity for endogenous glucose production (EGP). To date, the origin of residual EGP in GSDIa patients is unknown. Either increased glycogen debranching or lysosomal glycogen breakdown can account for residual EGP in GSDIa. Innovative treatments for GSDIa (e.g. AAV8-mediated gene therapy and mRNA therapy) are being developed.Therefore, longitudinal minimally-invasive monitoring of outcomes after therapeutic interventions in GSD Ia subjects becomes warranted. The primary objective is to test the feasibility of EGP quantification in adult GSDIa subjects by stable isotopes after a single oral [6,6-2H2]glucose dose. Secondary objectives are to compare EGP assessed by a single oral [6,6-2H2]glucose dose (a) in GSDIa patients versus matched healthy participants, (b) among GSDIa patients, (c) in the pre-prandial state versus the fed state, (d) in the controlled hospital setting versus the home setting. Data collected from the continuous glucose monitoring data will also be compared

NCT ID: NCT04309331 Completed - Metabolic Disease Clinical Trials

Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate that a new protein substitute is acceptable and well tolerated in children with PKU.